| Identification of drug and vaccine target in Mycobacterium leprae: A reverse vaccinology approach E Gupta, SRR Gupta, RRK Niraj International Journal of Peptide Research and Therapeutics 26, 1313-1326, 2019 | 14 | 2019 |
| Comparative proteome analysis of Mycobacterium tuberculosis Strains-H37Ra, H37Rv, CCDC5180, and CAS/NITR204: a step forward to identify novel drug targets SRR Gupta, E Gupta, A Ohri, SK Shrivastava, S Kachhwaha, V Sharma, ... Letters in Drug Design & Discovery 17 (11), 1422-1431, 2020 | 4 | 2020 |
| Plant-derived bioactive compounds in Neuroblastoma therapeutics: Current outlook and future perspective N Goswami, P Sethi, A Jyoti, G Nagar, SRR Gupta, A Singh, IK Singh Chemical Biology Letters 9 (4), 400-400, 2022 | 3 | 2022 |
| Molecular docking study to identify potent inhibitors of alpha-synuclein aggregation of Parkinson’s disease E Gupta, SR Gupta, A Kumar, A Kulshreshtha, RR Niraj | 3 | 2019 |
| Pepanalyzer: predicting peptide properties using its sequence V Rustagi, SRR Gupta, M Bajaj, A Singh, IK Singh Amino Acids 55 (10), 1371-1379, 2023 | 2 | 2023 |
| Breast Cancer Therapeutics and Hippo Signaling Pathway: Novel MicroRNA-Gene-Protein Interaction Networks SRR Gupta, G Nagar, P Mittal, S Rana, H Singh, R Singh, A Singh, ... OMICS: A Journal of Integrative Biology 27 (6), 273-280, 2023 | 2 | 2023 |
| Virtual screening of plant phytochemicals to discover potent Janus kinase-1 inhibitors against severe COVID-19 and sepsis K Joshi, SRR Gupta, S Verma, R Sharma, S Qureshi, MA Syed, V Nunia International Journal of Computational Biology and Drug Design 15 (5), 391-411, 2023 | 2 | 2023 |
| Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting G Nagar, P Mittal, SRR Gupta, M Pahuja, M Sanger, R Mishra, A Singh, ... Briefings in Functional Genomics 22 (2), 123-142, 2022 | 2 | 2022 |
| Deciphering mitogen activated protein kinase pathway activated during insect attack in Nicotiana attenuata KN Yajnik, SRR Gupta, M Taneja, IK Singh, A Singh Journal of Biomolecular Structure and Dynamics, 1-17, 2023 | 1 | 2023 |
| Beyond trial and error: Leveraging advanced software for Therapeutic discovery V Rustagi, SRR Gupta, A Singh, IK Singh Chemical Biology Letters 12 (1), 1251-1251, 2025 | | 2025 |
| Unlocking the Door for Precision Medicine in Rare Conditions: Structural and Functional Consequences of Missense ACVR1 Variants G Nagar, SRR Gupta, V Rustagi, RK Pramod, A Singh, M Pahuja, ... OMICS: A Journal of Integrative Biology 28 (10), 526-536, 2024 | | 2024 |
| Prognostic role of TEAD4 in TNBC: in-silico inhibition of the TEAD4-YAP interaction by flufenamic acid analogs SRR Gupta, S Singh, V Rustagi, M Pahuja, IR Mangangcha, M Rinchui, ... In Silico Pharmacology 12 (2), 64, 2024 | | 2024 |
| Validating The Anti-Cancer Potency Of A Novel ROR1 Inhibitor Against Triple-Negative Breast Cancer T Ta, VL Reed, N Chandra, N Dwyer, SR Gupta, IK Singh, N Fultang, ... Journal of Pharmacology and Experimental Therapeutics 389 (S3), 2024 | | 2024 |
| Abstract PO5-27-07: A novel ROR1 inhibitor CPD86 suppresses Triple-Negative Breast Cancer cells via regulation of AKT/GSK3β pathway T Ta, V Reed, N Chandra, N Dwyer, N Fultang, S Gupta, I Singh, ... Cancer Research 84 (9_Supplement), PO5-27-07-PO5-27-07, 2024 | | 2024 |
| Repurposing dihydroergotamine mesylate as a potential MCL-1 inhibitor and its antitumor effect in pancreatic cancer cells P Mittal, JH Lo, S Soni, F Battaglin, SRR Gupta, L Torres-Gonzalez, ... Cancer Research 84 (6_Supplement), 6001-6001, 2024 | | 2024 |
| Structure-based screening for potential ROR1 inhibitors and their potential as antitumor agents in pancreatic cancer cells IK Singh, SRR Gupta, P Mittal, S Soni, JH Lo, F Battaglin, Y Yang, ... Cancer Research 84 (6_Supplement), 4495-4495, 2024 | | 2024 |
| Silibinin: an inhibitor for a high-expressed BCL-2A1/BFL1 protein, linked with poor prognosis in breast cancer SRR Gupta, P Mittal, B Kundu, A Singh, IK Singh Journal of Biomolecular Structure and Dynamics, 1-11, 2023 | | 2023 |
| Identification and Validation of a Small Molecule Targeting ROR1 for the Treatment of Triple Negative Breast Cancer SRR Gupta, TM Ta, M Khan, A Singh, IK Singh, B Peethambaran Frontiers in Cell and Developmental Biology 11, 1243763, 2023 | | 2023 |
| Maiden Drug Designing Pipeline in R, using Open-source Tools, R Packages, and Machine Learning QSAR Models to Counter COVID SRR Gupta, S Verma, R Sharma, S Kachhwaha Life Sci 7 (6S), 95S-104S, 2021 | | 2021 |
Indrakant K. SinghMolecular Biology Research Lab. Department of Zoology, University of Delhi, Delhi-110019在 db.du.ac.in 的电子邮件经过验证
